Prevalencia de uso de antimicrobianos entre pacientes hospitalizados en áreas no críticas en un hospital universitario de México

Abstract

Señor editor: Enviamos los resultados de un estudio realizado en un hospital de referencia del área occidente del país concerniente a la prevalencia y justificación del uso de antimicrobianos…

Point prevalence survey of antibiotic use in hospitals in Latin American countries

“…The frequent use of 3GCs and carbapenems has also been reported from single-hospital studies in Peru 19 and Mexico. 20 Regarding the treatment of HAIs, 3GCs represented 16% of antibiotics used, higher than in Central Europe (2%–10%), 5 , 7 the USA (7%) 5 and Asia (10%–13%), 5 but lower than in Eastern Europe (20%). 5 Similarly, carbapenems were prescribed in 21% of cases, comparable with the 18%–20% in Asia, but higher than in Europe (8%–16%, depending on the region) 5 , 7 and the USA (7%).…”

Point Prevalence Survey of Antimicrobial Use in Four Tertiary Care Hospitals in Mexico

“…22,23,29 Furthermore, our results were higher than those reported previously by other tertiary care Mexican hospitals (59.3%, 51.5%). 14,30 Our findings also describe the extensive use of broadspectrum J01s such as ceftriaxone, meropenem, vancomycin, piperacillin, and clindamycin. These results are consistent with trends in the use of these antibiotics in Mexico and Latin America.…”

“…These results are consistent with trends in the use of these antibiotics in Mexico and Latin America. 13,14,17,23,30,31 Nevertheless, we identified even greater use proportions of these five antibiotics than those commonly found in Latin America, mainly ceftriaxone and meropenem. 23 These last two antibiotics belong to the WHO "Watch" group, only recommended for a specific and limited number of indications due to their elevated risk of resistant-bacteria selection.…”